Published on in Vol 10, No 6 (2021): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/30090, first published .
Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data

Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data

Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data

Carole Bandiera   1, 2, 3 * , PharmD ;   Evelina Cardoso   4 * , PharmD, PhD ;   Isabella Locatelli   3 , MSc, PhD ;   Antonia Digklia   5 , MD ;   Khalil Zaman   5 , MD, PhD ;   Antonella Diciolla   5 , MD ;   Valérie Cristina   5 , MD ;   Athina Stravodimou   5 , MD ;   Aedo Lopez Veronica   5 , MSc ;   Ana Dolcan   5 , MD ;   Apostolos Sarivalasis   5 , MD ;   Aikaterini Liapi   5 , MD ;   Hasna Bouchaab   5 , MD ;   Angela Orcurto   5 , MD ;   Jennifer Dotta-Celio   3 , PharmD, PhD ;   Solange Peters   5 , MD, PhD ;   Laurent Decosterd   6 , PharmD, PhD ;   Nicolas Widmer   2, 6, 7, 8 , PharmD, PhD ;   Dorothea Wagner   5 , MD, PhD ;   Chantal Csajka   2, 4, 8 * , PharmD, PhD ;   Marie Paule Schneider   1, 2 * , PharmD, PhD

1 School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland

2 Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland

3 Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland

4 Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland

5 Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland

6 Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland

7 Pharmacy of the Eastern Vaud Hospitals, Rennaz, Switzerland

8 School of Pharmaceutical Sciences, University of Lausanne, Lausanne, Switzerland

*these authors contributed equally

Corresponding Author: